Nonapeptide-1 has attracted sustained scientific curiosity due to its theorized role in modulating melanogenic signaling cascades within complex biological systems. Classified as a short-chain peptide ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

Brain function has traditionally been interpreted within a neuron-centric framework; however, this view has shifted toward a model of neuron-glia ...

Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...

Izzie Clarke: Hello and welcome to this Nature Custom Media podcast, supported by the Sigma-Aldrich® brand from Merck. I’m science journalist Izzie Clarke and in this episode, I explore how scientists ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators have defined a new genetic disease marked by premature aging and deficits in brain function.

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

As we age, our cells don’t just wear down—they reorganize. Researchers found that cells actively remodel a key structure called the endoplasmic reticulum, reducing protein-producing regions while ...

BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...